freeslots247| Humanwell Pharmaceutical: Controlling shareholder received warning letter from Hubei Securities Regulatory Bureau
editor 2024-05-17 17:35:29 Finance 40
News summary
[Humanwell Pharmaceutical: Controlling shareholder received warning letter from Hubei Securities Regulatory Bureau] Securities Times e Company News, Humanwell Pharmaceutical (600079) announced on the evening of May 17 that due to illegal reduction of holdings, Wuhan Contemporary Technology Industry Group Co., Ltd., the company's controlling shareholder, recently Received a certificate issued by Hubei Securities Regulatory Bureaufreeslots247administrative supervisionfreeslots247...
Newsletter text
[Humanwell Medicine: Controlling shareholder received warning letter from Hubei Securities Regulatory Bureau] Securities Times e Company News, Humanwell Pharmaceutical (600079) announced on the evening of May 17 that due to illegal reduction of shares, the company's controlling shareholder Wuhan Contemporary Technology Industry Group Co., Ltd. recently received a letter of administrative supervision issued by the Hubei Securities Regulatory Bureau. The decision on administrative supervision measures decided to take administrative supervision measures to issue a warning letter against Wuhan Contemporary Technology Industry Group Co., Ltd., and record relevant violations in the integrity file.